APA (7th ed.) Citation

Walsh, G. M. (2025). Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma. Antibodies (2073-4468), 14(4), 101. https://doi.org/10.3390/antib14040101

Chicago Style (17th ed.) Citation

Walsh, Garry M. "Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma." Antibodies (2073-4468) 14, no. 4 (2025): 101. https://doi.org/10.3390/antib14040101.

MLA (9th ed.) Citation

Walsh, Garry M. "Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma." Antibodies (2073-4468), vol. 14, no. 4, 2025, p. 101, https://doi.org/10.3390/antib14040101.